Impact BioMedical
IBO • XASE • Stock Fundamentals
Impact BioMedical is a pharmaceutical preparations company trading on XASE, led by CEO Frank D. Heuszel, with a market cap of $55.2M.
Market Cap$55.2M
Employees5.0
CEOFrank D. Heuszel
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Impact BioMedical FAQ
Common questions about Impact BioMedical
Impact BioMedical (IBO) has a market capitalization of $55.2M and trades on XASE.
Impact BioMedical has approximately 5 employees.